Smokingis the most commoncause of secondary polycythemia and mayinduce leukocytosis.
Introduction
Cigarette smoking is one of the largest public health problems in the world. Smokersare at greater risk for developing cancer, stroke and atherosclerosis. The risk of thromboembolic events, including brain infarction and myocardial infarction, are the most important disease entities. Thromboembolic episodes have a variety of etiologies.
Virchow identified three major risk factors for thrombosis: blood quality, state of the vasculature, and blood flow (1 ) . Polycythemia increases turbidity and induces rheological changes in blood. Polycythemia in smokers is thought to be due to the continuous exposure to carbon monoxidein tobacco smoke, whereexcessive and continuous exposure to carbon monoxidein smoke produces hypoxia (2) . However, Miller et al reported no detectable differences in the erythropoietin (Epo) concentration between smokers and nonsmokers (3).
Furthermore, smokers often are found to have incidental leukocytosis (4) . In most cases, the leukocyte count is normal on repeat examination, but a small percentage of people demonstrate persistent leukocytosis on serial examinations and are referred to a hematologist. Such patients are rarely found to be suffering from a myeloproliferative disorder. However, various studies, including the Edinburgh Artery Study (5) and the NHANES I Study (6) recently established leukocytosis as a risk factor in coronary artery disease. Therefore, ruling out myeloproliferative disease alone is not enough in patients with persistent leukocytosis. If the most important coronary risk factor in smokers is leukocytosis, the relationship between these two factors should be investigated more fully. As the sensitivity of the method of analysis had not been sufficient for detection of the normal granulocyte-colony stimulating factor (G-CSF)
level at less than 30 pg/ml, there has been no report measuring the serum concentration of G-CSFin smokers. But a new method using chemiluminescent compounds has provided an extremely sensitive mode for detection (7) . In this study, we examinedwhether Epo is responsible for smokers ' polycythemia, and measured the serum concentration of G-CSFin smokers and determined the relationship between smoking and leukocytosis.
From the Osaka National Hospital, Osaka, *the Department of Medicine III, HamamatsuUniversity School of Medicine, Hamamatsuand **Nippon Denso Co. higher in the subjects with leukocytosis (group C) than in those without leukocytosis (group B). In nonsmokers, Epo concentration, hemoglobinconcentration and hematocrit except platelet count showed no differences between the subjects with leukocytosis (group D) and those without leukocytosis (group A).
In this study, there were few subjects with a high hemoglobin concentration of greater than 1 7 g/dl. Therefore we divided the subjects into two groups by the hemoglobin concentration of 1 6 g/dl and we comparedthe Epo concentration in them. As shown in Table 2 , the Epo concentration was higher in the group with a high hemoglobin concentration of more than 16 g/dl than in the group with a low hemoglobin concentration of less than 16 g/dl in all subjects (p=0.04 by the Mann-Whitney's U test), in nonsmokers (p=0. 109), or in smokers (p=0.023), respectively. Week Week Figure 1 . Measurement of the serum erythropoietin and hematologic factors in three smokers before and after cessation of smoking. decreased levels for 20 weeks after cessation of smoking. On the other hand, the serum Epo concentration increased during the first 2 weeks after cessation of smoking, and then stabilized in two subjects and continued to increase in the other subjects.
Serum G-CSFConcentration in Smokers
In the subjects without leukocytosis, the mean G-CSF concentration tended to be higher in smokers (group F) than in nonsmokers (group E) (p=0. 101 by Mann-Whitney' s U-test) (Table 3 ). However, there were no significant differences in GCSFconcentrations in the other combinations of groups. The GCSFconcentration varied widely, especially among subjects with leukocytosis (groups G and H). No significant correlation was detected between the leukocyte counts and G-CSFconcentrations (data not shown).
Discussion
Numerousreports have documentedthat excessive carbon monoxide exposure caused by cigarette smoking produces polycythemia. Smith and Landaw have shown that smokers with elevated hematocrits have an increased blood carboxyhemoglobin, increased red-cell volume and reduced plasma volume (9). Galson et al have shownthat the Epogene is regulated by hypoxia-inducible cis-acting elements in the promoter and in the 3 ' enhancer (10). Therefore, it was thought that smoking provokes tissue hypoxia and induces Epo production, leading to increased red cell volume. However, Miller et al found no difference in Epo concentrations between menand women, smokers and nonsmokers, or different age groups (3). They also failed to detect differences in the Epo concentration when the carboxyhemoglobin concentration changed following the cessation of smoking. In the present study, smokers had a significantly lower serum Epo concentration than nonsmokers, although their hemoglobin concentration and hematocrit were high. However, smokers with the high hemoglobin concentration had a significantly higher serum Epo concentration than smokers with the low hemoglobin concentration. When smokers stopped smoking, the hematocrit and hemoglobin concentration decreased while the serum erythropoietin con- The kinetics of G-CSFmight be more complicated than those of Epo which regulates erythrocyte production. The G-CSF is usually produced and works in the hematopoietic microenvironment, however, a very small quantity of G-CSF is released into circulation and it mayreflect the production of G-CSF in the whole body. The effect of smoking on hemodynamics might also be mediated through biologically active substances, such as catecholamines and nicotine. Therefore, an interindividual variation in the G-CSFconcentration mayexist.
Cox et al have shown that neutrophil accumulation in the respiratory tract occurs in a variety of inflammatory disorders, especially in those associated with cigarette smoking, and that bronchial epithelial cells markedly increase the survival of humanneutrophils in vitro via the release of G-CSFand GM-CSF (1 1). The present results showed that the G-CSF concentration in smokers was not significantly higher than in nonsmokers. However, the G-CSFconcentration should decrease via negative feedback, if smoking releases leukocytes via factors other than G-CSF. Therefore, we think that the secretion of G-CSF may be one of the etiologies that chronic abuse of smoking induces leukocytosis, even though it is not solely responsible. Recently, leukocytosis has been shown to be an independent risk factor for coronary heart disease (5 , 1 2 smokers' leukocytosis to prevent ischemic heart disease.
